These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1153 related articles for article (PubMed ID: 29214601)

  • 21. Advances in stimuli responsive nanobiomaterials for cancer therapy.
    Sampathkumar K; Arulkumar S; Ramalingam M
    J Biomed Nanotechnol; 2014 Mar; 10(3):367-82. PubMed ID: 24730233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanomedicine in cancer treatment.
    Yih TC; Wei C
    Nanomedicine; 2005 Jun; 1(2):191-2. PubMed ID: 17292078
    [No Abstract]   [Full Text] [Related]  

  • 23. Emerging Use of Nanotechnology in the Treatment of Neurological Disorders.
    Chhabra R; Tosi G; Grabrucker AM
    Curr Pharm Des; 2015; 21(22):3111-30. PubMed ID: 26027574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanomedicine: the promise and challenges in cancer chemotherapy.
    Naguib YW; Cui Z
    Adv Exp Med Biol; 2014; 811():207-33. PubMed ID: 24683034
    [No Abstract]   [Full Text] [Related]  

  • 25. New Strategies in Cancer Nanomedicine.
    Tong R; Kohane DS
    Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors Influencing the Delivery Efficiency of Cancer Nanomedicines.
    Ullah R; Wazir J; Khan FU; Diallo MT; Ihsan AU; Mikrani R; Aquib M; Zhou X
    AAPS PharmSciTech; 2020 May; 21(4):132. PubMed ID: 32409932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in drug delivery systems for enhancing drug penetration into tumors.
    He B; Sui X; Yu B; Wang S; Shen Y; Cong H
    Drug Deliv; 2020 Dec; 27(1):1474-1490. PubMed ID: 33100061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report.
    Mignani S; Bryszewska M; Klajnert-Maculewicz B; Zablocka M; Majoral JP
    Biomacromolecules; 2015 Jan; 16(1):1-27. PubMed ID: 25426779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
    Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment.
    Afsharzadeh M; Hashemi M; Mokhtarzadeh A; Abnous K; Ramezani M
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1095-1110. PubMed ID: 28954547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting liposomes toward novel pediatric anticancer therapeutics.
    Federman N; Denny CT
    Pediatr Res; 2010 May; 67(5):514-9. PubMed ID: 20118828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanodelivery systems for improved topical antimicrobial therapy.
    Basnet P; Škalko-Basnet N
    Curr Pharm Des; 2013; 19(41):7237-43. PubMed ID: 23489202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide chemistry encounters nanomedicine: recent applications and upcoming scenarios in cancer.
    Falanga A; Galdiero S
    Future Med Chem; 2018 Aug; 10(16):1877-1880. PubMed ID: 29921135
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening.
    Millard M; Yakavets I; Zorin V; Kulmukhamedova A; Marchal S; Bezdetnaya L
    Int J Nanomedicine; 2017; 12():7993-8007. PubMed ID: 29184400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
    Alshememry AK; El-Tokhy SS; Unsworth LD
    Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive review.
    Ramasamy T; Ruttala HB; Gupta B; Poudel BK; Choi HG; Yong CS; Kim JO
    J Control Release; 2017 Jul; 258():226-253. PubMed ID: 28472638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives and opportunities for nanomedicine in the management of atherosclerosis.
    Lobatto ME; Fuster V; Fayad ZA; Mulder WJ
    Nat Rev Drug Discov; 2011 Oct; 10(11):835-52. PubMed ID: 22015921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.
    Han HS; Thambi T; Choi KY; Son S; Ko H; Lee MC; Jo DG; Chae YS; Kang YM; Lee JY; Park JH
    Biomacromolecules; 2015 Feb; 16(2):447-56. PubMed ID: 25565417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanomedicine: novel approaches in human and veterinary therapeutics.
    Irache JM; Esparza I; Gamazo C; Agüeros M; Espuelas S
    Vet Parasitol; 2011 Aug; 180(1-2):47-71. PubMed ID: 21680101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.